© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Hong Kong SAR

  • The Asia Pacific Loan Market Association named a new chairman at the annual general meeting in Hong Kong on Wednesday.
  • It was the best of times, it was the worst of times. It was the age of financial technology, it was the age of carrying your money around in a duffel bag. It was the epoch of cashless payment systems and disruption, it was the epoch of an old man riding an elephant over a mountain to the nearest bank branch.
  • English-language training provider Meten International Education Group filed an application with the US Securities and Exchange Commission on Wednesday for its proposed offering of American Depository Shares (ADS).
  • Consumer lending giant Home Credit is planning an IPO in Hong Kong that could raise about $1bn, according to a source familiar with the matter.
  • Société Générale has moved one of its London bankers to Hong Kong to take over as head of the Asia Pacific debt capital markets syndicate team.
  • Chinese clothing company Mulsanne Group Holding has priced its Hong Kong IPO below the indicative range, citing volatile markets fueled by the US-China trade war.
  • Hong Kong scored with a $1bn debut green bond this week, after investors poured more than $4bn into the transaction’s final order book. The deal was a strategic attempt by the government to encourage the development of green financing in the city, but the impact remains to be seen. Morgan Davis reports.
  • Haitong UniTrust International Leasing Corp has finally begun bookbuilding for an IPO, more than two years after it first announced plans to list on the Hong Kong Stock Exchange.
  • Xinyi Energy Holdings has come through tough market conditions to finalise its Hong Kong IPO, pricing the deal towards the bottom of the guidance range.
  • Hansoh Pharmaceutical Group has won approval from the Hong Kong Stock Exchange for a new listing worth up to $1bn.
  • Biopharmaceutical company Mabpharm has launched the deal roadshow for its IPO and is targeting proceeds of up to HK$1.53bn ($194.7m).
  • The market welcomed a dose of investment grade rated corporate and financial supply on Thursday. State-owned enterprise (SOE) Shougang Group saw its bond rally in the aftermarket, while onshore brokerage Huatai Securities and China Ping An Insurance Overseas also managed to price deals tightly.